Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington’s disease patients
Section snippets
Materials and methods
Subjects. Sixteen genetically confirmed HD patients and 36 age- and gender-matched healthy controls without any neurological disease were studied with care to avoid differences in confounding factors known to influence oxidative stress markers between HD and controls (Table 1). The Unified Huntington’s Disease Rating Scale (UHDRS) [20] were recorded for each patient. All of the subjects gave informed consent for the study.
Blood sample collection and preparation of leukocyte DNA and RNA. Blood
Clinical characteristics of HD patients
The clinical characteristics of the HD patients and controls are displayed in Table 1. There were no significant differences in age, gender, proportions of diabetes mellitus, hypertension, hyperlipidemia, smoking, and use of antioxidant between the HD (n = 16) and control groups (n = 36). The HD patients were divided into two disease severity groups according to their independence scales of UHDRS. Patients with scales ⩽70 represent the more severe group (HD1 group, n = 8). Patients with scales
Discussion
Impaired metabolism, mitochondrial abnormalities, and oxidative stress have been demonstrated in brain tissue for human and rodent models of HD [10], [11], [12], [13], [14], [15], [16]. Although, impaired metabolism and mitochondrial abnormalities have also been found in peripheral tissues [9], [17], [18], [19], direct evidence of increased oxidative stress and decreased anti-oxidant capacity was rarely shown in peripheral blood of HD patients [26].
A significant increase in 8-OHdG in HD caudate
Acknowledgments
This work was supported by Grants 23-4a and 23-5b from Academia Sinica, Taiwan, and CMRPG 32087 from Chang Gung Memorial Hospital, Taipei, Taiwan.
References (32)
- et al.
Oxidative damage to mitochondrial DNA in Huntington’s disease parietal cortex
Neurosci. Lett.
(1999) - et al.
Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples
J. Chromatogr. B.
(2002) - et al.
Rapid mtDNA deletion by oxidants in rat liver mitochondria after hemin exposure
Free Radical Biol. Med.
(2002) - et al.
Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress
Int. J. Biochem. Cell Biol.
(2005) - et al.
Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington’s disease
Brain Res.
(2000) - HDCRG, The Huntington’s Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is...
- et al.
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
Science
(1997) - et al.
Therapeutics development for triplet repeat expansion diseases
Nat. Rev. Genet.
(2005) - et al.
Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization
Nat. Med.
(1999) - et al.
Autophagosome-like vacuole formation in Huntington’s disease lymphoblasts
Neuroreport
(2004)
Akt is altered in an animal model of Huntington’s disease and in patients
Eur. J. Neurosci.
Adenosine A(2A) receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington’s disease
Am. J. Med. Genet. B Neuropsychiatr. Genet.
Genome-wide expression profiling of human blood reveals biomarkers for Huntington’s disease
Proc. Natl. Acad. Sci. USA
Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles
Brain
Oxidative damage and metabolic dysfunction in Huntington’s disease: selective vulnerability of the basal ganglia
Ann. Neurol.
Oxidative stress in Huntington’s disease
Brain Pathol.
Cited by (202)
Targeted to neuronal organelles for CNS drug development
2023, Advanced Drug Delivery ReviewsRole and mechanism of ferroptosis in neurological diseases
2022, Molecular MetabolismPan-neuronal expression of human mutant huntingtin protein in Drosophila impairs immune response of hemocytes
2022, Journal of Neuroimmunology